To clarify the role of body mass index (BMI, kg/m 2 ) adjustment in predictive models for cardiovascular events that add high-sensitivity C-reactive protein (hs-CRP) to the 10-y Framingham Coronary Heart Disease Risk Score (FCRS). DESIGN: A cross-sectional study in a group of apparently healthy individuals. SUBJECTS: In all, 1512 apparently healthy individuals (955 men and 557 women) at a respective age of 49.7710.6 and 50.679.6 y. RESULTS: The Pearson correlation between hs-CRP and the calculated 10-y FCRS was lower when adjusted for BMI. This reduction was especially noted in women where it dropped from 0.247 to 0.09. The dominant role of hs-CRP concentrations was also noted in a linear regression model, again, especially noted in women (drop of the standardized coefficient from 0.517 for BMI to 0.08 for the FCRS). CONCLUSION: The correlation between hs-CRP and the 10-y FCRS is partly related to the presence of obesity. We raise the possibility that the addition of BMI to the predictive model of FCRS might attenuate the cost-effectiveness of CRP measurements for this specific risk assessment.
Introduction
Both obesity and the calculated Framingham Coronary Heart Disease Risk Score (FCRS) are associated with increased morbidity and mortality. [1] [2] [3] A recent study by Albert et al 4 has shown a correlation between C-reactive protein (CRP) and the calculated 10-y FCRS. Being an effector in the atherothrombotic process and not only a biomarker, [5] [6] [7] [8] [9] [10] [11] [12] this protein might be part of the global risk that is attributed to the calculated 10-y FCRS.
We have presently focused on the role of obesity in the correlation that exists between high-sensitivity CRP (hs-CRP) concentration and the calculated 10-y FCRS.
This evaluation is essential for the understanding of the intercorrelations that exists between obesity, CRP and the 10-y FCRS.
Material and methods

Subjects
We have used the Database of the Tel Aviv Medical Center Inflammation Survey (TAMCIS). 13 This is a relatively large cohort of individuals attending the Tel Aviv Sourasky Medical Center for a routine health examination. Excluded from the analysis where individuals with known inflammatory disease (arthritis, inflammatory bowel disease), pregnancy, steroidal or nonsteroidal treatment (except for aspirin at a dose of r325 mg/dl), acute infection or invasive procedures (surgery, catheterization, etc) during the last 6 months. In addition, we excluded any individual missing one of the components of the FCRS as well as individuals younger than 30 y or older than 74 y.
Definition of risk factors
Diabetes mellitus was defined as a fasting blood glucose of Z126 mg/dl or the use of insulin or oral hypoglycemic agents, hypertension as blood pressures of Z140/90 mmHg or the use of antihypertensive medications, while hyperlipidemia was defined as cholesterol or triglyceride concentrations of Z200 mg/dl or the use of HMG-CoA reductase inhibitors or fibrates. As smokers, we included both present (at least five cigarettes per day) and past (did not smoke for the last 30 days or more) ones. ), all the inflammation markers, etc), and as the number of patients plus the percentage in each group for categorical variables (smoking and other cardiovascular risk factors, medications, etc). The crosstabs and descriptive procedures were used to produce frequencies of categorical variables and means7s.d. of continuous variables, respectively. The hs-CRP has non-normal distribution; thus, we used a logarithmic transformation that converts it into normal distribution for all the statistical procedures like correlations and regressions, and the results expressed as hs-CRP in the graph are a back-transformed geometrical mean and s.d. For all continuous variables, the comparison between the genders was performed using Student's t-test for independent samples. For all categorical variables, the Chi-Square Phi and Cramer's V statistics was used for assessing the overall significance between the genders. Pearson's partial correlations for confounding variables were used to evaluate the association between the log (hs-CRP) and the FCRS as well as the different components of the FCRS individually. All the correlations were done once bivariate and then adjusted for BMI, to evaluate the influence of BMI on these correlations. In order to assess whether BMI contributes information on the inflammation (represented as hs-CRP) to the risk beyond that conveyed by the 10-y risk calculated with the FCRS, we performed a linear regression using hs-CRP as the dependent variable and the FCRS plus BMI as the covariates using the stepwise method. The level of significance used for all of the above analyses was two tailed; Po0.05. The SPSS statistical package was used to perform all statistical evaluation (SSPS Inc., Chicago, IL, USA).
Determination of hs-CRP
Results
We have presently included a total of 1512 individuals who agreed to participate and signed an informed consent. These were 955 men and 557 women at respective mean7s.d. age of 49.7710.6 and 50.679.6 y (differences not significant). The mean7s.d. BMI in men was 27.373.6 kg/m 2 , while that in women was 26.574.8 kg/m 2 (P ¼ 0.001). Details related to the components of the calculated 10-y FCRS are reported in Table 1 , while the medications taken by these individuals are listed in Table 2 .
We have presently performed a Pearson's correlation between the concentration of hs-CRP and the calculated 10-y FCRS with and without adjustment for BMI. The results are presented in Table 3 and show a clear reduction in this correlation when adjusted for BMI. This reduction is noted especially in women where the coefficient of correlation drops from 0.248 to 0.09.
We have further used a linear regression model using the FCRS and BMI as the independent cofactors and hs-CRP as the dependent factor. The results are presented in Table 4 and show the dominant role of BMI on the FCRS in explaining the presence of enhanced hs-CRP concentrations. The dominance is especially strong in women where the standarized coefficients are 0.517 for BMI and 0.08 for the 10-y FCRS. The Pearson correlation coefficients between CRP and individual components of the FCRS are reported in Table 5 with and without adjustment for BMI. Again, it is clear that for each component of the FCRS, there is a decrement in the correlation following BMI adjustment. Finally, we present the relation between both hs-CRP and BMI with the calculated 10-y FCRS in Figure 1 for both men and women. It is evident that they increase parallel to the increment in the score.
Discussion
Recent studies have shown a role for hs-CRP as a biomarker for future vascular events. 15, 16 In this regard, it is interesting to note that it was found to correlate with the 10-y FCRS, a known and validated risk score. 4 This correlation is not surprising since it has been shown that hs-CRP correlated with each one of the components of the score including age, cholesterol, blood pressure, the presence of diabetes mellitus as well as smoking. [17] [18] [19] [20] The main finding of the present study is in the dominant effect that obesity has on the correlation between CRP and the 10-y calculated FCRS. Fat tissue is a known source of inflammatory cytokines 21 and the correlation between obesity and elevated concentrations of CRP is well documented. 22, 23 In addition, it has an influence on the expression of CRP in the various components on the metabolic syndrome, 19 part of which are also taken into consideration during the calculation of the 10-y FCRS. Therefore, it should be taken into consideration that correlations between CRP and various atherosclerotic risk factors should be corrected for BMI. This is essential since it is possible that deleterious aspects of obesity are responsible to the worse prognostic and not necessarily the CRP itself. The importance of BMI adjustment during the addition of CRP to other risk factors is shown in the results of the MONICA Augsburg cohort study. 24 In this study, a total of 2052 initially nondiabetic men were followed up for an average of 7.2 y. It was found that men with the CRP levels in the highest quartile had 2.7 times higher risk of developing diabetes. However, after further adjustment for BMI smoking and systolic pressure, the observed association became nonsignificant. Another example in that regard came from the Rotterdam study, which investigated the value of CRP in We conclude that the correlation between CRP and the 10-y FCRS is partly related to the presence of obesity. Therefore, it is possible that elevated CRP is in part a reflection of the presence of obesity in these individuals, suggesting that BMI adjustments should be included in predictive models where CRP is added to the FCRC. Based on the results of the present study, we raise the possibility that the addition of BMI to the predictive model of the FCRC might attenuate the costeffectiveness of CRP measurements for this specific risk assessment.
